Brief: Vaxart Announces Initiation Of Sentinel Cohort For Phase 2B Study Evaluating Its Covid-19 Oral Pill Vaccine Candidate
30/09/2024 21:58
Vaxart Inc VXRT.O :
* VAXART ANNOUNCES INITIATION OF SENTINEL COHORT FOR PHASE
2B
STUDY EVALUATING ITS COVID-19 ORAL PILL VACCINE CANDIDATE
Source text for Eikon: ID:nGNX5vMl9C
Further company coverage: VXRT.O
Recent news on Vaxart
See all newsBrief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Q2 revenue falls on lower government contract income
Brief: Vaxart Q2 Net Income USD -13.494 Million
Brief: Vaxart Enters Cooperation Agreement With Stockholder Group And Announces Board And Corporate Governance Enhancements
Vaxart Q1 revenue more than doubles on government contracts